The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug-Coated Balloons Market Research Report 2025

Global Drug-Coated Balloons Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1542128

No of Pages : 111

Ask Your Query
Synopsis
The global Drug-Coated Balloons market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug-Coated Balloons, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Coated Balloons.
Report Scope
The Drug-Coated Balloons market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug-Coated Balloons market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Coated Balloons manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
BD
B. Braun Melsungen
Koninklijke Philips
Boston Scientific
Opto Circuits (India)
Acotec Scientific
AR Baltic Medical
Acrostak
Biosensors International Group
BioMed
Concept Medical
Cardionovum
Endocor
Hexacath Sverige
iVascular SLU
Minvasys
MedAlliance
QT Vascular
RD Global-Invamed
SurModics
Terumo
Wellinq
Segment by Type
DCB for Peripheral Artery Disease
DCB for Coronary Artery Disease
DCB for Other Indications
Segment by Application
Hospitals
Cardiac Catheterization Labs
ASCs
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug-Coated Balloons manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug-Coated Balloons in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Drug-Coated Balloons Market Overview
1.1 Product Overview and Scope of Drug-Coated Balloons
1.2 Drug-Coated Balloons Segment by Type
1.2.1 Global Drug-Coated Balloons Market Value Comparison by Type (2024-2030)
1.2.2 DCB for Peripheral Artery Disease
1.2.3 DCB for Coronary Artery Disease
1.2.4 DCB for Other Indications
1.3 Drug-Coated Balloons Segment by Application
1.3.1 Global Drug-Coated Balloons Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Cardiac Catheterization Labs
1.3.4 ASCs
1.4 Global Drug-Coated Balloons Market Size Estimates and Forecasts
1.4.1 Global Drug-Coated Balloons Revenue 2019-2030
1.4.2 Global Drug-Coated Balloons Sales 2019-2030
1.4.3 Global Drug-Coated Balloons Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug-Coated Balloons Market Competition by Manufacturers
2.1 Global Drug-Coated Balloons Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug-Coated Balloons Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug-Coated Balloons Average Price by Manufacturers (2019-2024)
2.4 Global Drug-Coated Balloons Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug-Coated Balloons, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Coated Balloons, Product Type & Application
2.7 Drug-Coated Balloons Market Competitive Situation and Trends
2.7.1 Drug-Coated Balloons Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug-Coated Balloons Players Market Share by Revenue
2.7.3 Global Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Coated Balloons Retrospective Market Scenario by Region
3.1 Global Drug-Coated Balloons Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug-Coated Balloons Global Drug-Coated Balloons Sales by Region: 2019-2030
3.2.1 Global Drug-Coated Balloons Sales by Region: 2019-2024
3.2.2 Global Drug-Coated Balloons Sales by Region: 2025-2030
3.3 Global Drug-Coated Balloons Global Drug-Coated Balloons Revenue by Region: 2019-2030
3.3.1 Global Drug-Coated Balloons Revenue by Region: 2019-2024
3.3.2 Global Drug-Coated Balloons Revenue by Region: 2025-2030
3.4 North America Drug-Coated Balloons Market Facts & Figures by Country
3.4.1 North America Drug-Coated Balloons Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug-Coated Balloons Sales by Country (2019-2030)
3.4.3 North America Drug-Coated Balloons Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug-Coated Balloons Market Facts & Figures by Country
3.5.1 Europe Drug-Coated Balloons Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug-Coated Balloons Sales by Country (2019-2030)
3.5.3 Europe Drug-Coated Balloons Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Coated Balloons Market Facts & Figures by Country
3.6.1 Asia Pacific Drug-Coated Balloons Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug-Coated Balloons Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug-Coated Balloons Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug-Coated Balloons Market Facts & Figures by Country
3.7.1 Latin America Drug-Coated Balloons Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug-Coated Balloons Sales by Country (2019-2030)
3.7.3 Latin America Drug-Coated Balloons Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Coated Balloons Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Coated Balloons Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug-Coated Balloons Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug-Coated Balloons Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug-Coated Balloons Sales by Type (2019-2030)
4.1.1 Global Drug-Coated Balloons Sales by Type (2019-2024)
4.1.2 Global Drug-Coated Balloons Sales by Type (2025-2030)
4.1.3 Global Drug-Coated Balloons Sales Market Share by Type (2019-2030)
4.2 Global Drug-Coated Balloons Revenue by Type (2019-2030)
4.2.1 Global Drug-Coated Balloons Revenue by Type (2019-2024)
4.2.2 Global Drug-Coated Balloons Revenue by Type (2025-2030)
4.2.3 Global Drug-Coated Balloons Revenue Market Share by Type (2019-2030)
4.3 Global Drug-Coated Balloons Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug-Coated Balloons Sales by Application (2019-2030)
5.1.1 Global Drug-Coated Balloons Sales by Application (2019-2024)
5.1.2 Global Drug-Coated Balloons Sales by Application (2025-2030)
5.1.3 Global Drug-Coated Balloons Sales Market Share by Application (2019-2030)
5.2 Global Drug-Coated Balloons Revenue by Application (2019-2030)
5.2.1 Global Drug-Coated Balloons Revenue by Application (2019-2024)
5.2.2 Global Drug-Coated Balloons Revenue by Application (2025-2030)
5.2.3 Global Drug-Coated Balloons Revenue Market Share by Application (2019-2030)
5.3 Global Drug-Coated Balloons Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Drug-Coated Balloons Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Drug-Coated Balloons Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 B. Braun Melsungen
6.3.1 B. Braun Melsungen Corporation Information
6.3.2 B. Braun Melsungen Description and Business Overview
6.3.3 B. Braun Melsungen Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Melsungen Drug-Coated Balloons Product Portfolio
6.3.5 B. Braun Melsungen Recent Developments/Updates
6.4 Koninklijke Philips
6.4.1 Koninklijke Philips Corporation Information
6.4.2 Koninklijke Philips Description and Business Overview
6.4.3 Koninklijke Philips Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Koninklijke Philips Drug-Coated Balloons Product Portfolio
6.4.5 Koninklijke Philips Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Drug-Coated Balloons Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Opto Circuits (India)
6.6.1 Opto Circuits (India) Corporation Information
6.6.2 Opto Circuits (India) Description and Business Overview
6.6.3 Opto Circuits (India) Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Opto Circuits (India) Drug-Coated Balloons Product Portfolio
6.6.5 Opto Circuits (India) Recent Developments/Updates
6.7 Acotec Scientific
6.6.1 Acotec Scientific Corporation Information
6.6.2 Acotec Scientific Description and Business Overview
6.6.3 Acotec Scientific Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Acotec Scientific Drug-Coated Balloons Product Portfolio
6.7.5 Acotec Scientific Recent Developments/Updates
6.8 AR Baltic Medical
6.8.1 AR Baltic Medical Corporation Information
6.8.2 AR Baltic Medical Description and Business Overview
6.8.3 AR Baltic Medical Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AR Baltic Medical Drug-Coated Balloons Product Portfolio
6.8.5 AR Baltic Medical Recent Developments/Updates
6.9 Acrostak
6.9.1 Acrostak Corporation Information
6.9.2 Acrostak Description and Business Overview
6.9.3 Acrostak Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Acrostak Drug-Coated Balloons Product Portfolio
6.9.5 Acrostak Recent Developments/Updates
6.10 Biosensors International Group
6.10.1 Biosensors International Group Corporation Information
6.10.2 Biosensors International Group Description and Business Overview
6.10.3 Biosensors International Group Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biosensors International Group Drug-Coated Balloons Product Portfolio
6.10.5 Biosensors International Group Recent Developments/Updates
6.11 BioMed
6.11.1 BioMed Corporation Information
6.11.2 BioMed Drug-Coated Balloons Description and Business Overview
6.11.3 BioMed Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BioMed Drug-Coated Balloons Product Portfolio
6.11.5 BioMed Recent Developments/Updates
6.12 Concept Medical
6.12.1 Concept Medical Corporation Information
6.12.2 Concept Medical Drug-Coated Balloons Description and Business Overview
6.12.3 Concept Medical Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Concept Medical Drug-Coated Balloons Product Portfolio
6.12.5 Concept Medical Recent Developments/Updates
6.13 Cardionovum
6.13.1 Cardionovum Corporation Information
6.13.2 Cardionovum Drug-Coated Balloons Description and Business Overview
6.13.3 Cardionovum Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cardionovum Drug-Coated Balloons Product Portfolio
6.13.5 Cardionovum Recent Developments/Updates
6.14 Endocor
6.14.1 Endocor Corporation Information
6.14.2 Endocor Drug-Coated Balloons Description and Business Overview
6.14.3 Endocor Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Endocor Drug-Coated Balloons Product Portfolio
6.14.5 Endocor Recent Developments/Updates
6.15 Hexacath Sverige
6.15.1 Hexacath Sverige Corporation Information
6.15.2 Hexacath Sverige Drug-Coated Balloons Description and Business Overview
6.15.3 Hexacath Sverige Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hexacath Sverige Drug-Coated Balloons Product Portfolio
6.15.5 Hexacath Sverige Recent Developments/Updates
6.16 iVascular SLU
6.16.1 iVascular SLU Corporation Information
6.16.2 iVascular SLU Drug-Coated Balloons Description and Business Overview
6.16.3 iVascular SLU Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.16.4 iVascular SLU Drug-Coated Balloons Product Portfolio
6.16.5 iVascular SLU Recent Developments/Updates
6.17 Minvasys
6.17.1 Minvasys Corporation Information
6.17.2 Minvasys Drug-Coated Balloons Description and Business Overview
6.17.3 Minvasys Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Minvasys Drug-Coated Balloons Product Portfolio
6.17.5 Minvasys Recent Developments/Updates
6.18 MedAlliance
6.18.1 MedAlliance Corporation Information
6.18.2 MedAlliance Drug-Coated Balloons Description and Business Overview
6.18.3 MedAlliance Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.18.4 MedAlliance Drug-Coated Balloons Product Portfolio
6.18.5 MedAlliance Recent Developments/Updates
6.19 QT Vascular
6.19.1 QT Vascular Corporation Information
6.19.2 QT Vascular Drug-Coated Balloons Description and Business Overview
6.19.3 QT Vascular Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.19.4 QT Vascular Drug-Coated Balloons Product Portfolio
6.19.5 QT Vascular Recent Developments/Updates
6.20 RD Global-Invamed
6.20.1 RD Global-Invamed Corporation Information
6.20.2 RD Global-Invamed Drug-Coated Balloons Description and Business Overview
6.20.3 RD Global-Invamed Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.20.4 RD Global-Invamed Drug-Coated Balloons Product Portfolio
6.20.5 RD Global-Invamed Recent Developments/Updates
6.21 SurModics
6.21.1 SurModics Corporation Information
6.21.2 SurModics Drug-Coated Balloons Description and Business Overview
6.21.3 SurModics Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.21.4 SurModics Drug-Coated Balloons Product Portfolio
6.21.5 SurModics Recent Developments/Updates
6.22 Terumo
6.22.1 Terumo Corporation Information
6.22.2 Terumo Drug-Coated Balloons Description and Business Overview
6.22.3 Terumo Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Terumo Drug-Coated Balloons Product Portfolio
6.22.5 Terumo Recent Developments/Updates
6.23 Wellinq
6.23.1 Wellinq Corporation Information
6.23.2 Wellinq Drug-Coated Balloons Description and Business Overview
6.23.3 Wellinq Drug-Coated Balloons Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Wellinq Drug-Coated Balloons Product Portfolio
6.23.5 Wellinq Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Coated Balloons Industry Chain Analysis
7.2 Drug-Coated Balloons Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Coated Balloons Production Mode & Process
7.4 Drug-Coated Balloons Sales and Marketing
7.4.1 Drug-Coated Balloons Sales Channels
7.4.2 Drug-Coated Balloons Distributors
7.5 Drug-Coated Balloons Customers
8 Drug-Coated Balloons Market Dynamics
8.1 Drug-Coated Balloons Industry Trends
8.2 Drug-Coated Balloons Market Drivers
8.3 Drug-Coated Balloons Market Challenges
8.4 Drug-Coated Balloons Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock